Revenue for the quarter increased 29% year-on-year to ₹2,024.2 crore from ₹1,340 crore in the corresponding quarter of the previous year. EBITDA rose 30% year-on-year to ₹484.5 crore from ₹373 crore a year earlier. The EBITDA margin remained flat at 24% compared with the same period last year.
Organic revenue growth stood at 25.8% year-on-year (19.4% in constant currency terms) for the quarter. Adjusted EBITDA for the quarter came in at ₹503.6 crore, up 20.6% year-on-year, with the EBITDA margin at 24.9%.
ALSO READ | Sagility Q3 net jumps 23% to ₹268 cr as revenue soars 36%, margins steady
Adjusted profit after tax stood at ₹306.9 crore, up 28% year-on-year, with margins at 15.2%. Basic earnings per share stood at ₹0.56, up 41.2% year-on-year, while adjusted basic EPS was ₹0.66, up 28%.
For the full financial year FY26, revenue stood at ₹7,192.9 crore (₹71,929 million), up 29.1% year-on-year (23.6% in constant currency terms). Organic revenue growth was 20.1% (15% in constant currency terms).
Adjusted EBITDA for FY26 stood at ₹1,820 crore, up 23.9% year-on-year, with the EBITDA margin at 25.1%. Adjusted PAT stood at ₹1,130.6 crore, up 39.5% year-on-year, with a margin at 15.7%. Basic EPS for FY26 stood at ₹1.98, up 69.2% year-on-year, while adjusted EPS stood at ₹2.42, up 37.6%.
ALSO READ | Sagility India Q2 results: Profit doubles, revenue up 25%; declares dividend
On business updates, Sagility secured $30.7 million in potential steady-state ACV through new business wins and expansions under existing statements of work. The company added 17 new clients during FY26, including five in Q4, and expanded relationships across 20 existing clients.
Sagility said it continued advancing AI orchestration through its SmarTec and Synchrony suite of solutions, aimed at healthcare operations transformation. The company also completed its brand evolution, positioning it as a technology and AI-led healthcare operations partner. As of Q4FY26, Sagility had 46,860 employees and operated across five countries with 31 delivery centres.
The board of directors has recommended a final dividend of ₹0.10 per equity share of ₹10 each for the financial year ended March 31, 2026. The dividend payment is subject to approval of shareholders at the company’s ensuing annual general meeting. The company said details regarding the record date and dividend payment date will be announced in due course.
ALSO READ | Sagility shares surge up to 4% after over 69 crore shares change hands in multiple blocks
Ramesh Gopalan, Managing Director and Group CEO, said, “FY26 marked a year of strong execution for Sagility, driven by disciplined growth, improved cost management, and deeper engagement with our clients despite a challenging environment for US healthcare payers and providers.”
Shares of Sagility Ltd ended at ₹43.09, down by ₹1.91, or 4.24%, on the BSE today May 12.
